Bernstein Harold (CIK 2050172) reported 33 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell MAZE (13,409 shares), Buy MAZE (14,609 shares), Sell MAZE (1,200 shares), Buy MAZE (14,853 shares), Sell MAZE (13,253 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 13,409 | $400,460 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 14,609 | $152,226 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 1,200 | $36,404 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 14,853 | $154,768 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 13,253 | $338,940 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 1,600 | $42,172 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 15,000 | $156,300 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 15,000 | $393,354 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 15,000 | $156,300 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 11,352 | $331,948 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 3,348 | $100,636 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 300 | $9,320 |
| 2026-03-20 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 15,000 | $156,300 |
| 2026-03-20 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 6,161 | $296,960 |
| 2026-03-20 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 3,795 | $187,169 |
| 2026-03-20 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 5,044 | $252,301 |
| 2026-03-12 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 30,000 | $312,600 |
| 2026-03-12 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 29,652 | $1.5M |
| 2026-03-12 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 348 | $17,755 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 15,000 | $156,300 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 600 | $26,526 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 5,936 | $275,252 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 100 | $4,723 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 8,364 | $383,824 |
| 2026-01-09 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 25,156 | $262,126 |
Source: SEC Form 4 filings · as of 2026-07-02